- Grapefruit USA Inc. holds licensing for manufacturing and distribution in California, issued in 2018; the company is positioned as a premier distributor and manufacturer in the state, with a focus on procuring, manufacturing and distributing the highest-quality materials
- With cannabis legalization gaining momentum worldwide, Grapefruit is currently uniquely situated to disrupt the market through its novel and proprietary products and services
- The global cannabis market is expected to grow to $97.35 billion by 2026, expanding at a CAGR of 32.92%
- The company provides a wealth of cannabis flower and cannabis products to licensed businesses, along with various services including distribution, manufacturing, toll processing, sourcing and more
- The company has effectively used science and technology to create patented, truly disruptive products for the recreational and medicinal marketplace
- Grapefruit’s patented Hourglass(TM) topical delivery cream has solved the previously insurmountable difficulties of efficient skin absorption of THC and other cannabinoids
- Hourglass(TM) is manufactured exclusively at Grapefruit’s Coachillin facility by highly trained Grapefruit personnel and is available to the public only through Grapefruit authorized retailers; there is simply no other way possible for the public to obtain the benefits of the disruptive Hourglass experience
- Hourglass(TM) is a time-released topical cream that is available in full-spectrum and hemp-derived patented formulas
- The Hourglass(TM) topical delivery system features the Patchless Patch(TM) technology, providing a time-released full-spectrum entourage effect or a pure CBD experience
- Grapefruit will distribute the hemp-derived version of its Hourglass(TM) Topical Delivery Cream on a nationwide basis
Grapefruit USA (OTCQB: GPFT) is a Delaware corporation that is a fully licensed premier cannabis manufacturer and distributor in the legal cannabis marketplace with its own patented and branded line of products.
The company manufactures its patented product line and distributes it, along with other cannabis products, to all properly licensed…
NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://cnw.fm/GPFT
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.